BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 831619)

  • 1. Atypical melanosomal proteins in human malignant melanoma.
    Klingler WG; Montague PM; Chretien PB; Hearing VJ
    Arch Dermatol; 1977 Jan; 113(1):19-23. PubMed ID: 831619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature and biosynthesis of structural matrix protein in melanosomes: melanosomal structural protein as differentiation antigen for neoplastic melanocytes.
    Jimbow K; Yamana K; Akutsu Y; Maeda K
    Prog Clin Biol Res; 1988; 256():169-82. PubMed ID: 3368488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid composition in melanosomes of tumor- and chorioidea cells.
    Vedralová E; Duchon J; Zeman I
    Arch Geschwulstforsch; 1986; 56(5):329-34. PubMed ID: 3767601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and urine protein differences in patients with malignant melanoma.
    Tomecki KJ; Montague PM; Hearing VJ
    J Natl Cancer Inst; 1980 Jan; 64(1):29-32. PubMed ID: 6928045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of structural properties for morphological differentiation of melanosomes: II. Electron microscopic and SDS-PAGE comparison of melanosomal matrix proteins in B16 and Harding Passey melanomas.
    Jimbow K; Jimbow M; Chiba M
    J Invest Dermatol; 1982 Jan; 78(1):76-81. PubMed ID: 7054310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proceeding a protein factor re-establishing the contact-inhibition of hamster melanoma cells in vitro].
    Knecht M; Lipkin G
    Dermatologica; 1974; 148(5):275. PubMed ID: 4418288
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycoproteins as differentiation markers in human malignant melanoma and melanocytes.
    Tai T; Eisinger M; Ogata S; Lloyd KO
    Cancer Res; 1983 Jun; 43(6):2773-9. PubMed ID: 6850592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues.
    Dippold WG; Dienes HP; Knuth A; Meyer zum Büschenfelde KH
    Cancer Res; 1985 Aug; 45(8):3699-705. PubMed ID: 3893688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of a mouse monoclonal antibody, MoAb HMSA-1, against a melanosomal fraction of human malignant melanoma.
    Akutsu Y; Jimbow K
    Cancer Res; 1986 Jun; 46(6):2904-11. PubMed ID: 3516387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophoretic characterization of melanosomal proteins extracted from normal and malignant tissues.
    Hearing VJ; Eppig JJ
    Experientia; 1974 Sep; 30(9):1011-3. PubMed ID: 4413210
    [No Abstract]   [Full Text] [Related]  

  • 12. Soluble melanoprotein of tumor origin.
    Borovanský J; Hach P; Duchon J
    Neoplasma; 1975; 22(5):525-30. PubMed ID: 1196435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of biochemical properties of melanosomes for structural and functional differentiation: analysis of the compositions of lipids and proteins in melanosomes and their subfractions.
    Jimbow M; Kanoh H; Jimbow K
    J Invest Dermatol; 1982 Aug; 79(2):97-102. PubMed ID: 7097043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal protein synthesis in malignant melanoma cells.
    Hearing VJ; Nicholson JM
    Cancer Biochem Biophys; 1979; 4(2):59-68. PubMed ID: 552907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the amino acid composition of some tumor and normal melanosomes.
    Borovanský J; Duchon J
    Neoplasma; 1975; 22(2):195-9. PubMed ID: 1161115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody.
    Vogel AM; Esclamado RM
    Cancer Res; 1988 Mar; 48(5):1286-94. PubMed ID: 3342407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and ultrastructural localization of HMB-45 antigen.
    Kikuchi A; Shimizu H; Nishikawa T
    Br J Dermatol; 1996 Sep; 135(3):400-5. PubMed ID: 8949433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
    Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
    Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor progression in the human melanocytic system.
    Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
    Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.